Response to the European Medicines Agency regarding ‘Draft guideline on the clinical development of medicinal products for the treatment of Autism Spectrum Disorder’

In 2016, the European Medicines Agency published a draft guideline for research on medicinal products for ASD. Together with other autistic-led advocacy organizations in Europe, ASY drafted and submitted a response which aimed to introduce the perspectives of autistic adults into the process, and to correct certain shortcomings and inaccuracies in the draft. In addition … Read moreResponse to the European Medicines Agency regarding ‘Draft guideline on the clinical development of medicinal products for the treatment of Autism Spectrum Disorder’